Three items verified; placeholders removed.
Verified
Ziftomenib — KURA: FDA approved Nov 13.
Plozasiran — ARWR: PDUFA Nov 18.
Avance® Nerve Graft — AXGN: PDUFA Dec 5.
Removed/Deferred (TBD pending primary sources)
Rocatinlimab (AMG 451)
Nirsevimab
Mitapivat (timing clarified to ASH Dec 6–9; separate PDUFA timing under reconfirmation)
PRAX-628 (conference data only; next topline 1H 2026)
Palazestrant/OP-1250 (SABCS trial-in-progress poster; non-binary)
We’ve updated the live list accordingly. Back to regular cadence on Monday.